BIOPIX DNA TECHNOLOGY S.A.’s Post

View organization page for BIOPIX DNA TECHNOLOGY S.A., graphic

2,459 followers

Since the beginning of the COVID-19 pandemic, the circulating variants have been classified into different categories depending on the impact they may have on the epidemiological situation. The three main categories are: variant under monitoring (VUM), variant of interest (VOI) and variant of concern (VOC)1-4. BIOPIX DNA TECHNOLOGY P.C. has been constantly stayed alert and evaluated every new variant that had been identified regardless its classification, to ensure that the COV19 qcLAMP kit5 is able to detect every variant that is circulating. To do that, the company is performing in silico analysis and identifying whether the new mutations are interfering with the accuracy of the kit. In conclusion, the effectiveness of COV19 qcLAMP test kit should not be affected by any circulating variant, including the latest JN.1 (BA.2.86.1.1), and it is able to detect any SARS-COV-2 variant that is known until this day1-4.     References 1.     Tracking SARS-CoV-2 variants. https://lnkd.in/gSnTf3NT. Last updated on 26 October 2023. 2.     SARS-CoV-2 variants of concern as of 20 October 2023. https://lnkd.in/d33TM2Jr. Last updated on 20 October 2023. 3.     Pango Lineages: Latest epidemiological lineages of SARS-CoV-2. https://lnkd.in/gSQZbKUj. 4.     Genomic epidemiology of SARS-CoV-2. https://lnkd.in/gcTPj7VH. 5.     BIOPIX DNA TECHNOLOGY P.C. COV19 qcLAMP test kit. https://lnkd.in/gtwXbYPN.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics